Zepp Health Corporation
ZEPP
$8.62
-$0.38-4.22%
NYSE
| 12/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -48.24% | -51.00% | -51.97% | -49.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -48.24% | -51.00% | -51.97% | -49.31% |
| Cost of Revenue | -- | -56.85% | -60.43% | -61.62% | -56.89% |
| Gross Profit | -- | -23.94% | -18.56% | -12.16% | -16.31% |
| SG&A Expenses | -- | 0.00% | -13.56% | -25.50% | -29.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -40.04% | -47.21% | -52.29% | -50.23% |
| Operating Income | -- | -55.01% | 8.36% | 55.39% | 59.28% |
| Income Before Tax | -- | -85.18% | 19.16% | 56.09% | 59.28% |
| Income Tax Expenses | -- | 663.46% | 152.07% | 128.10% | 111.58% |
| Earnings from Continuing Operations | -- | -143.72% | 0.91% | 38.56% | 47.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 13.25% | -67.65% | -46.02% | -36.36% |
| Net Income | -- | -144.00% | 0.73% | 38.54% | 47.82% |
| EBIT | -- | -55.01% | 8.36% | 55.39% | 59.28% |
| EBITDA | -- | -79.77% | 8.78% | 64.56% | 68.15% |
| EPS Basic | -- | -130.94% | 6.14% | 41.97% | 49.28% |
| Normalized Basic EPS | -- | -94.32% | 26.24% | 69.39% | 69.39% |
| EPS Diluted | -- | -122.46% | 3.57% | 39.23% | 47.05% |
| Normalized Diluted EPS | -- | -94.09% | 26.29% | 69.34% | 69.34% |
| Average Basic Shares Outstanding | -- | 6.39% | 4.41% | 2.65% | 0.71% |
| Average Diluted Shares Outstanding | -- | 4.99% | 3.04% | 3.98% | 2.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |